In HNSCC, MALAT1 could activate NF-κB and β-catenin pathway at the posttranslational level, in which the degradation of P65/β-catenin was repressed in a VHL-dependent manner; 2. The gene discussed is MALAT1; the disease is head and neck squamous cell carcinoma.